Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000932799-08-000125
Filing Date
2008-06-12
Accepted
2008-06-12 13:58:01
Documents
1
Period of Report
2008-06-10

Document Format Files

Seq Description Document Type Size
1 duerden4_ex.html 4  
1 duerden4_ex.xml 4 3233
  Complete submission text file 0000932799-08-000125.txt   4973
Mailing Address 45 ABINGDON VILLAS LONDON X0 W8
Business Address 011442079370492
DUERDEN JOHN H (Reporting) CIK: 0001296981 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33204 | Film No.: 08895111

Mailing Address 310 GOLDEN SHORE LONG BEACH CA 90802
Business Address 310 GOLDEN SHORE LONG BEACH CA 90802 562-628-1007
Obagi Medical Products, Inc. (Issuer) CIK: 0001375247 (see all company filings)

EIN.: 954658730 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations